Date: 08/04/2020 The Secretary I Execltive Director BSE Ltd, National Stock Exchange of India Limited Dear Sir/Madam, Ref: Dr. Reddy's Laboratories Limited Stock Code: BSE-500124 NSE-DRDDY-EQ Sub: Disclosures under Regulations 30(3) and 31(5) of the Securities and Exchange Board of dia (Substantial Acquisition of Shares and Takeover) Regulations, 2011. With rerence to the above, we are enclosing a statement showing the aggregate shareholding of the promoter group I psons acting in concert along with the copies of disclosures under Regulations 30(1), 30(2) and 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeover) Regulations, 2011, received om the respective individual/entities. With regards, t , J ( � s�h Reddy - Enc: as above· CC: 1. Dr. Reddy's Laboratories Limited 2. New York Stock Exchange, Inc.
Transcript
Date: 08/04/2020
The Secretary I Execl.ltive Director
BSE Ltd,
National Stock Exchange of India Limited
Dear Sir/Madam,
Ref: Dr. Reddy's Laboratories Limited
Stock Code: BSE-500124
NSE-DR.REDDY-EQ
Sub: Disclosures under Regulations 30(3) and 31(5) of the Securities and Exchange Board of India
(Substantial Acquisition of Shares and Takeover) Regulations, 2011.
With reference to the above, we are enclosing a statement showing the aggregate shareholding of the
promoter group I persons acting in concert along with the copies of disclosures under Regulations
30(1), 30(2) and 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of
Shares and Takeover) Regulations, 2011, received from the respective individual/entities.
With regards,
t(i,J(�s'J�h Reddy
-
Enc: as above·
CC: 1. Dr. Reddy's Laboratories Limited
2. New York Stock Exchange, Inc.
Part-B**
Name of the Target Company: Dr. Reddy's Laboratories Limited
Sr.No. Name of the person and Persons Acting in Concert (PAC) with the person
1. G. V. ·Prasad2. Kallam Satish Reddy 3. Kallam Samrajyam 4. G. Anuradha5. Dr. Reddy's Holdings Limited 6. K. Deepti Reddy7. APS Trust 8. VSD Holdings & Advisory LLP 9. K. Satish Reddy (HUF)10. G. Vani Sanjana Reddy11. G. Mallika Reddy12. G. V. Prasad (HUF)13. G Sharathchandra Reddy14. K Shravva Reddy 15. K Vishal Reddy
rG 11�--
Satish Reddy
Place:
Hyderabad Date:
08/04/2020
Whether the person belongs to Promoter/ Promoter group
Statement showing the shareholding of Promoter Group and Persons Acting in Concert
Sr. Name of the Promoters and
No. persons acting in concert
1. G. V. Prasad 2. Kallam Satish Reddy3. Kallam Samrajyam4. G. Anuradha 5. Dr. Reddy's Holdings Limited6. K. Deepti Reddy7. APS Trust 8. VSD Holdings & Advisory LLP9. K. Satish Reddy (HUF)10. G. Vani Sanjana Reddy11. G. Mallika Reddy 12. G. V. Prasad (HUF) 13. G Sharathchandra Reddy14. K Shravya Reddy15. K Vishal Reddy
Total
<(�� Jc-;r° Sat�Reddy
Place: Hyderabad Date: 08/04/2020
Number of % w.r.t. total % of fotal diluted shares held share /voting share/voting capital of
as on capital TC assuming full 31.03.2020 conversion of the
outstanding convertible
securities/warrants into equity shares of
the TC 1,117,940 0.67 0.67
898,432 0.54 0.54
1,115,360 0.67 0.67
1,496 0.00 0.00
41,325,300 24.87 24.87
Nil Nil Nil
Nil Nil Nil
Nil Nil Nil
Nil Nil Nil
Nil Nil Nil
Nil Nil Nil
Nil Nil Nil
Nil Nil NilNil Nil NilNil Nil Nil
4,44,58,528 26.75 26.75
ANNEXURE-1
Format for Disclosures under Regulation 30(1), 30(2) and 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011
Part-A-Details of Shareholding
1. Name of the Target Company (TC)
2. Name(s) of the Stock Exchange(s)where the shares of the TC are listed
3. Particulars of the shareholder:
Dr. Reddy's Laboratories Limited
1. BSE Ltd.2. National Stock Exchange of India Limited.
3. New York Stock Exchange Inc.
a. Name of person(s) together with NA Person Acting in Concert (PAC)whose total holding (including thatin the form of shares, warrants,convertible securities and any otherinstrument that would entitle theholder to receive shares in the TC) ismore than 25% of the voting rightsofthe TC.or
b. Name(s) of promoter(s), member ofthe promoter group and PAC withhim.
4. Particulars of the shareholding ofperson(s) mentioned at (3) above
As on March 31, 2020, holding of:
a) Sharesb) Voting Rights ( otherwise than by
shares)c) Warrants,d) Convertible Securitiese) Any other instrument that would
entitle the holder to receive shares inthe TC.
Total
Mr. G V Prasad
Number of % w. r. t. total shares share /voting
capital wherever applicable
1,117,940
1,117,940
There is no encumbrance (directly or indirectly) on these shares.
0.67
0.67
% of total diluted share/voting capital of TC
(*)
0.67
0.67
(*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.
Place: Hyderabad Date: 01/04/2020
w G V Prasad
ANNEXURE-1
Format for Disclosures under Regulation 30(1), 30(2) and 31(4) of SEBI (Substantial
Acquisition of Shares & Takeov•ers) Regulations, 20H
Part-A-Details of Shareholding
1. Name of the Target Company (TC)
2. Name(s) of the Stock Exchange(s)where the shares of the TC are listed
3. Particulars of the shareholder:a. Name of person(s) together with
Person Acting in Concert (PAC)whose total holding (including thatm the form of shares, warrants,convertible securities and any otherinstrument that would entitle theholder to receive shares in the TC) ismore than 25% of the voting rightsof the TC.or
Dr. Reddy' s Laboratories Limited
1. BSE Ltd.2. National Stock Exchange of India Limited.3. New York Stock Exchange Inc.
NA
b. Name(s) of promoter(s), member of Mr. Kallam Satish Reddythe promoter group and PAC withhim.
4. Particulars of the shareholding ofperson(s) mentioned at (3) above
Number of % w. r. t. total shares share /voting
capital wherever applicable
% of total diluted share/voting capital of TC (*)
As on March 31, 2020, holding of:
a) Sharesb) Voting Rights ( otherwise than by
shares)c) Warrants,d) Convertible Securitiese) Any other instrument that would
entitle the holder to receive shares inthe TC.
Total
898,432
898,432
There is no encumbrance ( directly or indirectly) on these shares.
0.54 0.54
0.54 0.54
(*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.
Place: Hyderabad Date: 01/04/2020
(j'i{,�,�i---.i
Kallam Satish Reddy
ANNEXURE-1
Format for Disclosures under Regulation 30(1), 30(2) and 31(4) of n bs tan tiaJ
Acquisition of Shares & Takeovers) Regulations, 2011
Part-A-Details of Shareholding
1. Name of the Target Company (TC)
2. Name(s) of the Stock Exchange(s)where the shares of the TC are listed
3. Particulars of the shareholder:a. Name of person(s) together with
Person Acting m Concert (PAC)whose total holding (including thatm the form of shares, warrants,convertible securities and any otherinstrument that would entitle theholder to receive shares in the TC) ismore than 25% of the voting rightsof the TC.or
b. Name(s) of promoter(s), member ofthe promoter group and PAC withhim.
4. Particulars of the shareholding ofperson(s) mentioned at (3) above
As on March 31, 2020, holding of:
a) Sharesb) Voting Rights ( otherwise than by
shares)c) Warrants,d) Convertible Securitiese) Any other instrument that would
entitle the holder to receive shares inthe TC.
Total
Dr. Reddy's Laboratories Limited
1. BSE Ltd.2. National Stock Exchange oflndia Limited.3. New York Stock Exchange Inc.
NA
Mrs. Kallam Samrajyam
Number of % w. r. t. total shares
1,115,360
1,115,360
share /voting capital wherever applicable
0.67
0.67
% of total diluted share/voting capital of TC (*)
0.67
0.67
There is no encumbrance ( directly or indirectly) on these shares.
(*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.
Place: Hyderabad Date: 01/04/2020
Kallam Samrajyam
ANNEXURE-1
Format for Disclosures under Regulation 30(1), 30(2) and 31(4) of SEBI {Substantial Acquisition of Shares & Takeovers) Regulations, 2011
Part-A-Details of Shareholding
1. Name of the Target Company (TC)
2. Name(s) of the Stock Exchange(s)where the shares of the TC are listed
3. Particulars of the shareholder:a. Name of person(s) together with
Person Acting in Concert (PAC)whose total holding (including thatin the form of shares, warrants,convertible securities and any otherinstrument that would entitle theholder to receive shares in the TC) ismore than 25% of the voting rightsof the TC.or
Dr. Reddy's Laboratories Limited
1. BSE Ltd.2. National Stock Exchange of India Limited.3. New York Stock Exchange Inc.
NA
b. Name(s) of promoter(s), member of Mrs. G Anuradha the promoter group and PAC withhim.
4. Particulars of the shareholding ofperson(s) mentioned at (3) above
As on March 31, 2020, holding of:
a) Sharesb) Voting Rights ( otherwise than by
shares)c) Warrants,d) Convertible Securitiese) Any other instrument that would
entitle the holder to receive shares inthe TC.
Total
Number of % w. r. t. total shares share /voting
capital wherever applicable
1,496
1,496
There is no encumbrance (directly or indirectly) on these shares.
0.00
0.00
% of total diluted share/voting capital of TC (*)
0.00
0.00
(*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.
Place: Hyderabad Date: 01/04/2020
C.A\A�G Anuradha
ANNEXURE-1
Format for Disclosures under Regulation 30(1), 30(2) and 31 (4) of SEBI (Substantial
Acquisition of Shares & Takeovers) Regulations, 2011
Part-A-Details of Shareholding
1. Name of the Target Company (TC)
2. Name(s) of the Stock Exchange(s)where the shares of the TC are listed
3. Particulars of the shareholder:a. Name of person(s) together with
Person Acting in Concert (PAC)whose total holding (including thatm the form of shares, warrants,convertible securities and any otherinstrument that would entitle theholder to receive shares in the TC) ismore than 25% of the voting rightsof the TC.or
b. Name(s) of promoter(s), member ofthe promoter group and PAC withhim.
4. Particulars of the shareholding ofperson(s) mentioned at (3) above
As on March 31, 2020, holding of:
a) Sharesb) Voting Rights ( otherwise than by
shares)c) Warrants,d) Convertible Securitiese) Any other instrument that would
entitle the holder to receive shares inthe TC.
Total
Dr. Reddy's Laboratories Limited
1. BSE Ltd.2. National Stock Exchange of India Limited.3. New York Stock Exchange Inc.
NA
Dr. Reddy's Holdings Limited
Number of % w. r. t. total shares share /voting
capital wherever applicable
41,325,300
41,325,300
24.87
24.87
% of total diluted share/voting capital of TC (*)
24;87
24.87
There is no encumbrance ( directly or indirectly) on these shares.
(*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.
Place: Hyderabad Date: 01/04/2020
For Dr. Reddy's Holdings Limited
-(� d' (--==5{;:A�sh Reddy Director
ANNEXURE-1
Format for Disclosures under Regulation 30(1). 30(2) and 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011
Part-A-Details of Shareholding
1. Name of the Target Company (TC)
2. Name(s) of the Stock Exchange(s)where the shares of the TC are listed
3. Particulars of the shareholder:a. Name of person(s) together with
Person Acting m Concert (PAC)whose total holding (including thatm the form of shares, warrants,convertible securities and any otherinstrument that would entitle theholder to receive shares in the TC) ismore than 25% of the voting rightsof the TC.or
Dr. Reddy's Laboratories Limited
1. BSE Ltd.2. National Stock Exchange oflndia Limited.3. New York Stock Exchange Inc.
NA
b. Name(s) of promoter(s), member of Mrs. K Deepti Reddythe promoter group and PAC withhim.
4. Particulars of the shareholding ofperson(s) mentioned at (3) above
As on March 31, 2020, holding of:
a) Sharesb) Voting Rights ( otherwise than by
shares)c) Warrants,d) Convertible Securitiese) Any other instrument that would
entitle the holder to receive shares inthe TC.
Total
Number of % w. r. t. total shares
Nil
Nil
share /voting capital wherever applicable
Encumbrance (directly or indirectly) on shares - Not applicable
Nil
Nil
% of total diluted share/voting capital of TC (*)
Nil
Nil
(*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.
ti j),vfil -µ__a; Place: Hyderabad K Deepti Reddy Date: 01/04/2020
ANNEXURE-1
Format for Disclosures under Regulation 30(1), 30(2) and 31(4) of SEBI (Substantial
Acquisition of Shnrcs & Takcovc1·s) Regulations, 201 J
Part-A-Details of Shareholding
1. Name of the Target Company (TC)
2. Name(s) of the Stock Exchange(s)where the shares of the TC are listed
3. Particulars of the shareholder:a. Name of person(s) together with
Person Acting m Concert (PAC)whose total holding (including thatm the form of shares, warrants,convertible securities and any otherinstrument that would entitle theholder to receive shares in the TC) ismore than 25% of the voting rightsof the TC.or
Dr. Reddy's Laboratories Limited
1. BSE Ltd.2. National Stock Exchange of India Limited.3. New York Stock Exchange Inc.
NA
b. Name(s) of promoter(s), member of APS Trust the promoter group and PAC withhim.
4. Particulars of the shareholding ofperson(s) mentioned at (3) above
As on March 31, 2020, holding of:
a) Sharesb) Voting Rights ( otherwise than by
shares)c) Warrants,d) Convertible Securitiese) Any other instrument that would
entitle the holder to receive shares inthe TC.
Total
Number of % w. r. t. total shares
Nil
Nil
share /voting capital wherever applicable
Encumbrance (directly or indirectly) on shares - Not applicable.
Nil
Nil
% of total diluted share/voting capital of TC (*)
Nil
Nil
{*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.
Place: Hyderabad Date: 01/04/2020
For AP S Trust
rfl)�Authorised Signatory
ANNEXURE-1
Format for Disclosures under Regulation 30(1), 30(2) and 31(4) of SEBI (Substantial
Acquisition of Shares & Takeovers) Regulations, 2011
Part-A-Details of Shareholding
1. Name of the Target Company (TC)
2. Name(s) of the Stock Exchange(s)where the shares of the TC are listed
3. Particulars of the shareholder:a. Name of person(s) together with
Person Acting m Concert (PAC)
whose total holding (including thatm the form of shares, warrants,convertible securities and any other
instrument that would entitle theholder to receive shares in the TC) is
more than 25% of the voting rightsof the TC.
orb. Name(s) of promoter(s), member of
the promoter group and PAC withhim.
4. Particulars of the shareholding ofperson(s) mentioned at (3) above
As on March 31, 2020, holding of:
a) Shares
b) Voting Rights ( otherwise than byshares)
c) Warrants,d) Convertible Securities
e) Any other instrument that wouldentitle the holder to receive shares inthe TC.
Total
Dr. Reddy's Laboratories Limited
1. BSE Ltd.2. National Stock Exchange oflndia Limited.3. New York Stock Exchange Inc.
NA
VSD Holdings & Advisory LLP
Number of % w. r. t. total shares share /voting
capital wherever applicable
Nil
Nil
Nil
Nil
% of total diluted share/voting capital of TC (*)
Encumbrance (directly or indirectly) on shares - Not applicable
Nil
Nil
(*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.
Place: Hyderabad Date: 01/04/2020
For VSD Holdings & Advisory LLP
((;\ /1� ---r- .�
A thorised Signatory
ANNEXURE-1
Format for Disclosures under Regulation 30(1), 30(2) and 31(4) of SEBI (Substantial Acquisition of Shares & Takeo ers) Regulations, 2011
Part-A-Details of Shareholding
1. Name of the Target Company (TC)
2. Name(s) of the Stock Exchange(s)where the shares of the TC are listed
3. Particulars of the shareholder:a. Name of person(s) together with
Person Acting m Concert (PAC)whose total holding (including thatm the form of shares, warrants,convertible securities and any otherinstrument that would entitle theholder to receive shares in the TC) ismore than 25% of the voting rightsof the TC.or
Dr. Reddy's Laboratories Limited
1. BSE Ltd.2. National Stock Exchange of India Limited.3. New York Stock Exchange Inc.
NA
b. Name(s) of promoter(s), member of K Satish Reddy (HUF) the promoter group and PAC withhim.
4. Particulars of the shareholding ofperson(s) mentioned at (3) above
As on March 31, 2020, holding of:
a) Sharesb) Voting Rights ( otherwise than by
shares)c) Warrants,d) Convertible Securitiese) Any other instrument that would
entitle the holder to receive shares inthe TC.
Total
Number of % w. r. t. total shares share /voting
capital wherever applicable
Nil
Nil
Encumbrance (directly or indirectly) on shares - Not applicable
Nil
Nil
% of total diluted share/voting capital of TC (*)
Nil
Nil
(*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.
Place: Hyderabad Date: 01/04/2020
K Satish Reddy HUF Karta
ANNEXURE-1
Format for Disclosures under Regulation 30(1), 30(2) and 31(4) of SEBJ (Substantial Acquisition of Shares & Takeovers) Regulations, 2011
Part-A-Details of Shareholding
1. Name of the Target Company (TC) Dr. Reddy' s Laboratories Limited
1. BSE Ltd.2. Name(s) of the Stock Exchange(s)where the shares of the TC are listed 2. National Stock Exchange of India Limited.
3. New York Stock Exchange Inc.3. Particulars of the shareholder:
a. Name of person(s) together with NA Person Acting in Concert (PAC)whose total holding (including thatin the form of shares, warrants,convertible securities and any otherinstrument that would entitle theholder to receive shares in the TC) ismore than 25% of the voting rightsofthe TC.or
b. Name(s) of promoter(s), member of Ms. G Vani Sanjana Reddy the promoter group and PAC withhim.
4. Particulars of the shareholding ofperson(s) mentioned at (3) above
As on March 31, 2020, holding of:
a) Sharesb) Voting Rights ( otherwise than by
shares)c) Warrants,d) Convertible Securitiese) Any other instrument that would
entitle the holder to receive shares inthe TC.
Total
Number of % w. r. t. total shares share /voting
capital wherever applicable
Nil
Nil
Encumbrance (directly or indirectly) on shares - Not applicable
Nil
Nil
% of total diluted share/voting capital of TC (*)
Nil
Nil
(*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.
Place: Hyderabad Date: 01/04/2020
G Vani Sanjana Reddy
ANNEXURE-1
Format for Disclosures under Regulation 30(1), 30(2) and 31(4) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011
Part-A-Details of Shareholding
1. Name of the Target Company (TC)
2. Name(s) of the Stock Exchange(s)where the shares of the TC are listed
3. Particulars of the shareholder:
Dr. Reddy's Laboratories Limited
I. BSE Ltd.2. National Stock Exchange of India Limited.3. New York Stock Exchange Inc.
a. Name of person(s) together with NAPerson Acting in Concert (PAC)whose total holding (including thatin the form of shares, warrants,convertible securities and any otherinstrument that would entitle theholder to receive shares in the TC) ismore than 25% of the voting rightsofthe TC.or
b. Name(s) of promoter(s), member ofthe promoter group and PAC withhim.
4. Particulars of the shareholding ofperson(s) mentioned at (3) above
As on March 31, 2020, holding of:
a) Sharesb) Voting Rights ( otherwise than by
shares)c) Warrants,d) Convertible Securitiese) Any other instrument that would
entitle the holder to receive shares inthe TC.
Total
Ms. G Mallika Reddy
Number of % w. r. t. total shares share /voting
capital wherever applicable
Nil
Nil
Encumbrance (directly or indirectly) on shares - Not applicable.
Nil
Nil
% of total diluted share/voting capital of TC (*)
Nil
Nil
(*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.
Place: Hyderabad. Date: 01/04/2020
G Mallika Reddy
ANNEXURE-1
Format for Disclosures under Regulation 30(1 ), 30(2) and 31(4) of SEBJ (SubstantialAcquisition of Shares & Takeovers) Regulations, 2011
Part-A-Details of Shareholding
1. Name of the Target Company (TC)
2. Name(s) of the Stock Exchange(s)where the shares of the TC are listed
3. Particulars of the shareholder:a. Name of person(s) together with
Person Acting m Concert (PAC)whose total holding (including thatm the form of shares, warrants,convertible securities and any otherinstrument that would entitle theholder to receive shares in the TC) ismore than 25% of the voting rightsof the TC.or
b. Namc(s) of promotcr(s), member ofthe promoter group and PAC withhim.
4. Particulars of the shareholding ofperson(s) mentioned at (3) above
As on March 31, 2020, holding of:
a) Sharesb) Voting Rights ( otherwise than by
shares)c) Warrants,d) Convertible Securitiese) Any other instrument that would
entitle the holder to receive shares inthe TC.
Total
Dr. Reddy's Laboratories Limited
1. BSE Ltd.2. National Stock Exchange of India Limited.3. New York Stock Exchange Inc.
NA
G V Prasad (I IUP)
Number of % w. r. t. total shares share /voting
capital wherever applicable
Nil
Nil
Nil
Nil
% of total diluted share/voting capital of TC (*)
Encumbrance (directly or indirectly) on shares - Not applicable
Nil
Nil
(*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.
Place: Hyderabad Date: 01/04/2020
GV�HUF Karta
ANNEXURE-1
Format for Disclosures under Regulation 30(1), 30(2) and 31 (4) of SEBJ (Substantial
Acquisition of Shares & Takeovers) Regulations, 2011
Part-A-Details of Shareholding
1. Name of the Target Company (TC) Dr. Reddy's Laboratories Limited
1. BSE Ltd.2. Name(s) of the Stock Exchange(s)where the shares of the TC are listed 2. National Stock Exchange of India Limited.
3. New York Stock Exchange Inc.3. Particulars of the shareholder:
a. Name of person(s) together with NAPerson Acting in Concert (PAC)whose total holding (including thatin the form of shares, warrants,convertible securities and any otherinstrument that would entitle theholder to receive shares in the TC) ismore than 25% of the voting rightsofthe TC.or
b. Name(s) of promoter(s), member of Mr. G Sharathchandra Reddythe promoter group and PAC withhim.
4. Particulars of the shareholding ofperson(s) mentioned at (3) above
As on March 31, 2020, holding of:
a) Sharesb) Voting Rights ( otherwise than by
shares)c) Warrants,d) Convertible Securitiese) Any other instrument that would
entitle the holder to receive shares inthe TC.
Total
Number of % w. r. t. total shares
Nil
Nil
share /voting capital wherever applicable
Encumbrance (directly or indirectly) on shares - Not applicable.
Nil
Nil
% of total diluted share/vot�ng capital of TC (*)
Nil
Nil
(*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.
Place: Hyderabad Date: 01/04/2020
G Sharathchandra Reddy
ANNEXURE-1
Format for Disclosures under Regulation 30(1). 30(2) and 31(4) of SEBI (Substantial
Acquisition of Shares & Takeovers) Regulations, 2011
Part-A-Details of Shareholding
1. Name of the Target Company (TC)
2. Name(s) of the Stock Exchange(s)where the shares of the TC are listed
3. Particulars of the shareholder:a. Name of person(s) together with
Person Acting m Concert (PAC)whose total holding (including thatm the form of shares, warrants,convertible securities and any otherinstrument that would entitle theholder to receive shares in the TC) ismore than 25% of the voting rightsof the TC.or
Dr. Reddy's Laboratories Limited
1. BSE Ltd.2. National Stock Exchange oflndia Limited.3. New York Stock Exchange Inc.
NA
b. Name(s) of promoter(s), member of Ms. K Shravya Reddy the promoter group and PAC withhim.
4. Particulars of the shareholding ofperson(s) mentioned at (3) above
As on March 31, 2020, holding of:
a) Sharesb) Voting Rights ( otherwise than by
shares)c) Warrants,d) Convertible Securitiese) Any other instrument that would
entitle the holder to receive shares inthe TC.
Total
Number of % w. r. t. total shares
Nil
Nil
share /voting capital wherever applicable
Encumbrance (directly or indirectly) on shares - Not applicable
Nil
Nil
% of total diluted share/voting capital of TC (*)
Nil
Nil
(*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.
Place: Hyderabad K Shravya Reddy Date: 07/04/2020
ANNEXURE-1
Format for Disclosures under Regulation 30(1), 30(2) and 31(4) of SEBl (SubstantiaJ
Acquisition of Shares & Takeovers) Regulations, 2011
Part-A-Details of Shareholding
1. Name of the Target Company (TC)
2. Name(s) of the Stock Exchange(s)where the shares of the TC are listed
3. Particulars of the shareholder:a. Name of person(s) together with
Person Acting m Concert (PAC)whose total holding (including thatm the form of shares, warrants,convertible securities and any otherinstrument that would entitle theholder to receive shares in the TC) ismore than 25% of the voting rightsof the TC.or
b. Name(s) of promoter(s), member ofthe promoter group and PAC withhim.
4. Particulars of the shareholding ofperson(s) mentioned at (3) above
As on March 31, 2020, holding of:
a) Sharesb) Voting Rights ( otherwise than by
shares)c) Warrants,d) Convertible Securities
. e) Any other instrument that would entitle the holder to receive shares in the TC.
Total
Dr. Reddy's Laboratories Limited
1. BSE Ltd.2. National Stock Exchange oflndia Limited.3. New York Stock Exchange Inc.
NA
K Vishal Reddy
Number of % w. r. t. total shares share /voting
capital wherever applicable
Nil
Nil
Nil
Nil
% of total diluted share/voting capital of TC (*)
Encumbrance (directly or indirectly) on shares - Not applicable
Nil
Nil
(*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.
